The global Intravenous (IV) Solutions market is projected to grow from US$ 11660 million in 2023 to US$ 15800 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Intravenous (IV) Solutions Market

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Market Analysis and Insights: Global Intravenous (IV) Solutions Market

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 77%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Includes

This report presents an overview of global market for Intravenous (IV) Solutions market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Intravenous (IV) Solutions, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Intravenous (IV) Solutions, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous (IV) Solutions revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Intravenous (IV) Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Intravenous (IV) Solutions revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo) and Grifols S.A. (Spain), etc.

Scope of Intravenous (IV) Solutions Market Report

Report Metric	Details
Report Name	Intravenous (IV) Solutions Market
Accounted market size in 2023	US$ 11660 million
Forecasted market size in 2029	US$ 15800 million
CAGR	5.2
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Peripheral Parenteral Nutrition Total Parenteral Nutrition
Segment by Application	Hospital & Clinics Ambulatory Home Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Intravenous (IV) Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous (IV) Solutions companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous (IV) Solutions revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Intravenous (IV) Solutions Market growing?

Ans: The Intravenous (IV) Solutions Market witnessing a CAGR of 5.2 during the forecast period 2023-2029.

What is the Intravenous (IV) Solutions Market size in 2029?

Ans: The global Intravenous (IV) Solutions market is projected to grow from US$ 11660 million in 2023 to US$ 15800 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

What is the market share of major companies in Intravenous (IV) Solutions Market?

Ans: Global top three manufacturers hold a share over 35%.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Peripheral Parenteral Nutrition

1.2.3 Total Parenteral Nutrition

1.3 Market by Application

1.3.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital & Clinics

1.3.3 Ambulatory

1.3.4 Home Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intravenous (IV) Solutions Market Perspective (2018-2029)

2.2 Global Intravenous (IV) Solutions Growth Trends by Region

2.2.1 Intravenous (IV) Solutions Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2018-2023)

2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029)

2.3 Intravenous (IV) Solutions Market Dynamics

2.3.1 Intravenous (IV) Solutions Industry Trends

2.3.2 Intravenous (IV) Solutions Market Drivers

2.3.3 Intravenous (IV) Solutions Market Challenges

2.3.4 Intravenous (IV) Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Intravenous (IV) Solutions by Players

3.1.1 Global Intravenous (IV) Solutions Revenue by Players (2018-2023)

3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2018-2023)

3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Intravenous (IV) Solutions, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Intravenous (IV) Solutions Market Concentration Ratio

3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2022

3.5 Global Key Players of Intravenous (IV) Solutions Head office and Area Served

3.6 Global Key Players of Intravenous (IV) Solutions, Product and Application

3.7 Global Key Players of Intravenous (IV) Solutions, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Intravenous (IV) Solutions Breakdown Data by Type

4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2018-2023)

4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029)

5 Intravenous (IV) Solutions Breakdown Data by Application

5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2018-2023)

5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Intravenous (IV) Solutions Market Size (2018-2029)

6.2 North America Intravenous (IV) Solutions Market Size by Type

6.2.1 North America Intravenous (IV) Solutions Market Size by Type (2018-2023)

6.2.2 North America Intravenous (IV) Solutions Market Size by Type (2024-2029)

6.2.3 North America Intravenous (IV) Solutions Market Share by Type (2018-2029)

6.3 North America Intravenous (IV) Solutions Market Size by Application

6.3.1 North America Intravenous (IV) Solutions Market Size by Application (2018-2023)

6.3.2 North America Intravenous (IV) Solutions Market Size by Application (2024-2029)

6.3.3 North America Intravenous (IV) Solutions Market Share by Application (2018-2029)

6.4 North America Intravenous (IV) Solutions Market Size by Country

6.4.1 North America Intravenous (IV) Solutions Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Intravenous (IV) Solutions Market Size by Country (2018-2023)

6.4.3 North America Intravenous (IV) Solutions Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Intravenous (IV) Solutions Market Size (2018-2029)

7.2 Europe Intravenous (IV) Solutions Market Size by Type

7.2.1 Europe Intravenous (IV) Solutions Market Size by Type (2018-2023)

7.2.2 Europe Intravenous (IV) Solutions Market Size by Type (2024-2029)

7.2.3 Europe Intravenous (IV) Solutions Market Share by Type (2018-2029)

7.3 Europe Intravenous (IV) Solutions Market Size by Application

7.3.1 Europe Intravenous (IV) Solutions Market Size by Application (2018-2023)

7.3.2 Europe Intravenous (IV) Solutions Market Size by Application (2024-2029)

7.3.3 Europe Intravenous (IV) Solutions Market Share by Application (2018-2029)

7.4 Europe Intravenous (IV) Solutions Market Size by Country

7.4.1 Europe Intravenous (IV) Solutions Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Intravenous (IV) Solutions Market Size by Country (2018-2023)

7.4.3 Europe Intravenous (IV) Solutions Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Intravenous (IV) Solutions Market Size (2018-2029)

8.2 China Intravenous (IV) Solutions Market Size by Type

8.2.1 China Intravenous (IV) Solutions Market Size by Type (2018-2023)

8.2.2 China Intravenous (IV) Solutions Market Size by Type (2024-2029)

8.2.3 China Intravenous (IV) Solutions Market Share by Type (2018-2029)

8.3 China Intravenous (IV) Solutions Market Size by Application

8.3.1 China Intravenous (IV) Solutions Market Size by Application (2018-2023)

8.3.2 China Intravenous (IV) Solutions Market Size by Application (2024-2029)

8.3.3 China Intravenous (IV) Solutions Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Intravenous (IV) Solutions Market Size (2018-2029)

9.2 Asia Intravenous (IV) Solutions Market Size by Type

9.2.1 Asia Intravenous (IV) Solutions Market Size by Type (2018-2023)

9.2.2 Asia Intravenous (IV) Solutions Market Size by Type (2024-2029)

9.2.3 Asia Intravenous (IV) Solutions Market Share by Type (2018-2029)

9.3 Asia Intravenous (IV) Solutions Market Size by Application

9.3.1 Asia Intravenous (IV) Solutions Market Size by Application (2018-2023)

9.3.2 Asia Intravenous (IV) Solutions Market Size by Application (2024-2029)

9.3.3 Asia Intravenous (IV) Solutions Market Share by Application (2018-2029)

9.4 Asia Intravenous (IV) Solutions Market Size by Region

9.4.1 Asia Intravenous (IV) Solutions Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Intravenous (IV) Solutions Market Size by Region (2018-2023)

9.4.3 Asia Intravenous (IV) Solutions Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Type

10.2.1 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Application

10.3.1 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country

10.4.1 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 ICU Medical Inc. (U.S.)

11.1.1 ICU Medical Inc. (U.S.) Company Details

11.1.2 ICU Medical Inc. (U.S.) Business Overview

11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction

11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.1.5 ICU Medical Inc. (U.S.) Recent Developments

11.2 B. Braun Melsungen AG (Germany)

11.2.1 B. Braun Melsungen AG (Germany) Company Details

11.2.2 B. Braun Melsungen AG (Germany) Business Overview

11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction

11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.2.5 B. Braun Melsungen AG (Germany) Recent Developments

11.3 Fresenius Kabi AG (Germany)

11.3.1 Fresenius Kabi AG (Germany) Company Details

11.3.2 Fresenius Kabi AG (Germany) Business Overview

11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction

11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.3.5 Fresenius Kabi AG (Germany) Recent Developments

11.4 Baxter (U.S.)

11.4.1 Baxter (U.S.) Company Details

11.4.2 Baxter (U.S.) Business Overview

11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction

11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.4.5 Baxter (U.S.) Recent Developments

11.5 Amanta Healthcare (India)

11.5.1 Amanta Healthcare (India) Company Details

11.5.2 Amanta Healthcare (India) Business Overview

11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction

11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.5.5 Amanta Healthcare (India) Recent Developments

11.6 Terumo Medical Corporation (Tokyo)

11.6.1 Terumo Medical Corporation (Tokyo) Company Details

11.6.2 Terumo Medical Corporation (Tokyo) Business Overview

11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction

11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.6.5 Terumo Medical Corporation (Tokyo) Recent Developments

11.7 Grifols S.A. (Spain)

11.7.1 Grifols S.A. (Spain) Company Details

11.7.2 Grifols S.A. (Spain) Business Overview

11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction

11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023)

11.7.5 Grifols S.A. (Spain) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ICU Medical Inc. (U.S.)

B. Braun Melsungen AG (Germany)

Fresenius Kabi AG (Germany)

Baxter (U.S.)

Amanta Healthcare (India)

Terumo Medical Corporation (Tokyo)

Grifols S.A. (Spain)

List of Tables

Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Peripheral Parenteral Nutrition

Table 3. Key Players of Total Parenteral Nutrition

Table 4. Global Intravenous (IV) Solutions Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Intravenous (IV) Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Intravenous (IV) Solutions Market Share by Region (2018-2023)

Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Intravenous (IV) Solutions Market Share by Region (2024-2029)

Table 10. Intravenous (IV) Solutions Market Trends

Table 11. Intravenous (IV) Solutions Market Drivers

Table 12. Intravenous (IV) Solutions Market Challenges

Table 13. Intravenous (IV) Solutions Market Restraints

Table 14. Global Intravenous (IV) Solutions Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Intravenous (IV) Solutions Revenue Share by Players (2018-2023)

Table 16. Global Top Intravenous (IV) Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)

Table 17. Global Intravenous (IV) Solutions Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Intravenous (IV) Solutions, Headquarters and Area Served

Table 20. Global Key Players of Intravenous (IV) Solutions, Product and Application

Table 21. Global Key Players of Intravenous (IV) Solutions, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2018-2023)

Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2024-2029)

Table 27. Global Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Intravenous (IV) Solutions Revenue Share by Application (2018-2023)

Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Intravenous (IV) Solutions Revenue Share by Application (2024-2029)

Table 31. North America Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Intravenous (IV) Solutions Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Intravenous (IV) Solutions Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Intravenous (IV) Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Intravenous (IV) Solutions Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Intravenous (IV) Solutions Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Intravenous (IV) Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Intravenous (IV) Solutions Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Intravenous (IV) Solutions Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Intravenous (IV) Solutions Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Intravenous (IV) Solutions Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Intravenous (IV) Solutions Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Intravenous (IV) Solutions Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Intravenous (IV) Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)

Table 63. ICU Medical Inc. (U.S.) Company Details

Table 64. ICU Medical Inc. (U.S.) Business Overview

Table 65. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product

Table 66. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 67. ICU Medical Inc. (U.S.) Recent Developments

Table 68. B. Braun Melsungen AG (Germany) Company Details

Table 69. B. Braun Melsungen AG (Germany) Business Overview

Table 70. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product

Table 71. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 72. B. Braun Melsungen AG (Germany) Recent Developments

Table 73. Fresenius Kabi AG (Germany) Company Details

Table 74. Fresenius Kabi AG (Germany) Business Overview

Table 75. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product

Table 76. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 77. Fresenius Kabi AG (Germany) Recent Developments

Table 78. Baxter (U.S.) Company Details

Table 79. Baxter (U.S.) Business Overview

Table 80. Baxter (U.S.) Intravenous (IV) Solutions Product

Table 81. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 82. Baxter (U.S.) Recent Developments

Table 83. Amanta Healthcare (India) Company Details

Table 84. Amanta Healthcare (India) Business Overview

Table 85. Amanta Healthcare (India) Intravenous (IV) Solutions Product

Table 86. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 87. Amanta Healthcare (India) Recent Developments

Table 88. Terumo Medical Corporation (Tokyo) Company Details

Table 89. Terumo Medical Corporation (Tokyo) Business Overview

Table 90. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product

Table 91. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 92. Terumo Medical Corporation (Tokyo) Recent Developments

Table 93. Grifols S.A. (Spain) Company Details

Table 94. Grifols S.A. (Spain) Business Overview

Table 95. Grifols S.A. (Spain) Intravenous (IV) Solutions Product

Table 96. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)

Table 97. Grifols S.A. (Spain) Recent Developments

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Intravenous (IV) Solutions Market Share by Type: 2022 VS 2029

Figure 3. Peripheral Parenteral Nutrition Features

Figure 4. Total Parenteral Nutrition Features

Figure 5. Global Intravenous (IV) Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Intravenous (IV) Solutions Market Share by Application: 2022 VS 2029

Figure 7. Hospital & Clinics Case Studies

Figure 8. Ambulatory Case Studies

Figure 9. Home Care Case Studies

Figure 10. Intravenous (IV) Solutions Report Years Considered

Figure 11. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Intravenous (IV) Solutions Market Share by Region: 2022 VS 2029

Figure 14. Global Intravenous (IV) Solutions Market Share by Players in 2022

Figure 15. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2022

Figure 17. North America Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Intravenous (IV) Solutions Market Share by Type (2018-2029)

Figure 19. North America Intravenous (IV) Solutions Market Share by Application (2018-2029)

Figure 20. North America Intravenous (IV) Solutions Market Share by Country (2018-2029)

Figure 21. United States Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Intravenous (IV) Solutions Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Intravenous (IV) Solutions Market Share by Type (2018-2029)

Figure 25. Europe Intravenous (IV) Solutions Market Share by Application (2018-2029)

Figure 26. Europe Intravenous (IV) Solutions Market Share by Country (2018-2029)

Figure 27. Germany Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Intravenous (IV) Solutions Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Intravenous (IV) Solutions Market Share by Type (2018-2029)

Figure 35. China Intravenous (IV) Solutions Market Share by Application (2018-2029)

Figure 36. Asia Intravenous (IV) Solutions Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Intravenous (IV) Solutions Market Share by Type (2018-2029)

Figure 38. Asia Intravenous (IV) Solutions Market Share by Application (2018-2029)

Figure 39. Asia Intravenous (IV) Solutions Market Share by Region (2018-2029)

Figure 40. Japan Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Intravenous (IV) Solutions Market Share by Country (2018-2029)

Figure 50. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 57. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 58. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 59. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 60. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 61. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 62. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cryochambers Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37W6047

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Drug Repurposing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23J5563

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Consumer mHealth Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11I6310

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions